Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 5 Esophageal Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Neoplasms 3 Head and Neck Neoplasms 3 Prostatic Neoplasms 2 Phyllodes Tumor 2 Carcinoma, Squamous Cell 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Thymoma 1 Stomach Neoplasms 1 Sarcoma 1 Postoperative Complications 1 Oropharyngeal Neoplasms 1 Neoplastic Cells, Circulating 1 Mouth Neoplasms 1 Lymphatic Metastasis 1 Liver Neoplasms 1 Laryngeal Neoplasms 1 Laryngeal Diseases 1 High-Risk Cancer 1 Endometrial Neoplasms 1 Carcinoma, Lobular 1 Carcinoma, Hepatocellular 1 Breast Cancer Radiotherapy 1

Interventions

Gemcitabine 157 Cisplatin 117 pembrolizumab 81 Cystectomy 46 Nivolumab 42 Carboplatin 42 Paclitaxel 41 Mitomycin 41 Docetaxel 39 atezolizumab 33 Magnetic Resonance Spectroscopy 33 Radiotherapy 31 durvalumab 30 avelumab 26 BCG Vaccine 26 Specimen Handling 25 Cystoscopy 24 enfortumab vedotin 23 Doxorubicin 23 Fluorouracil 20 Methotrexate 17 Vinblastine 16 Standard of Care 15 Ipilimumab 14 Filgrastim 14 5-aminolevulinic acid hexyl ester 14 Transurethral Resection of Bladder 13 Surgical Procedures, Operative 13 Sunitinib 13 Biopsy 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Urinary Bladder Neoplasms × Radiotherapy, Adjuvant × Clear all

NCT05445648 2022-12-28

CBPTMI

First Affiliated Hospital Xi'an Jiaotong University

Phase 2 Unknown

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡